Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission-Reference-Cited by-同舟云学术

Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission

Published:2013-06-11 Issue:2 Volume:98 Page:186-196
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Eto Tetsuya,Takase Ken,Miyamoto Toshihiro,Ohno Yuju,Kamimura Tomohiko,Nagafuji Koji,Takamatsu Yasushi,Teshima Takanori,Gondo Hisashi,Taniguchi Shuichi,Akashi Koichi,Harada Mine

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-013-1378-9.pdf

Reference32 articles.

1. Seshadri T, Keating A. Is there a role for autotransplants in AML in first remission? Biol Blood Marrow Transpl. 2009;15:17–20.

2. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood. 2000;96:4075–83.

3. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al.; European LeukemiaNet. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–74.

4. Cornelissen JJ, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM, et al. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood. 2007;109:3658–66.

5. Gondo H, Harada M, Miyamoto T, Takenaka K, Tanimoto K, Mizuno S, et al. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transpl. 1997;20:821–6.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT;Bone Marrow Transplantation;2023-08-08

2. Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the EBMT;2023-06-05

3. Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission;International Journal of Hematology;2017-12-14

4. Autologous stem cell transplantation versus alternative allogeneic donor transplants in adult acute leukemias;Seminars in Hematology;2016-04

5. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects;Bone Marrow Transplantation;2015-08-17